Model N Continues to Build Momentum in Life Science Industry with Wins in Global Top Ten Accounts Running SAP ERP

Share Article

Company also joins SAP® PartnerEdgeâ„¢ Program

We are pleased to welcome these important new customers to the Model N community and look forward to continuing to attract and partner with the major innovators in the Life Science industry

Model N, Inc., the leader in Revenue Management solutions, today announced that it continues to build momentum among industry-leading Pharmaceutical, Biotech, and Medical Device manufacturers. The growing recognition of Model N's proven, domain-specific Revenue Management platform is reflected in a slate of global Top Ten customer wins in recent months.

Momentum Highlights

  •     An industry-leading Drug and Device manufacturer has selected Model N's full Pharmaceutical and Medical Technology Commercial Revenue Management Suites to align its business-critical pricing, contracting, and settlements processes across both its U.S. and international businesses. After an extensive evaluation by the customer of competitive solutions, including incumbent contracting solutions, the manufacturer decided Model N was best suited to handle its growing commercial business requirements.
  •     A top international Life Sciences company has selected the entire Model N Revenue Management Suite to align pricing, contracting, settlements, and regulatory processes across its numerous pharmaceutical and medical device divisions. Pre-implementation planning and testing has already begun.
  •     A global Top Ten Biopharma leader has selected Model N's full Pharmaceutical Commercial Revenue Management Suite to align its pricing, sell-side contract, and settlements processes across its global operations. The selection comes after an extensive evaluation by the customer of dedicated contract management solutions. Implementation for the global deployment is underway.

Model N Revenue Management Suite and SAP® ERP

These wins reflect the leadership position Model N has attained in the Life Science industry with its integrated, end-to-end Revenue Management platform. In addition, all three customers are complementing existing investments in SAP® (NYSE: SAP) solutions by deploying Model N's proven fifth-generation Revenue Management Suite with the SAP ERP application using adaptors that leverage the same interfaces used to connect SAP applications.

Model N has recently joined the SAP PartnerEdgeâ„¢ program as an SAP software solution partner. Through the program, partners work closely with SAP to develop and certify the technical integration of their solutions with SAP software. Integrated partner applications extend, complement, and add value to SAP solutions, thereby helping mutual customers more successfully meet business needs and drive strong results.

Supporting Quote

"We are pleased to welcome these important new customers to the Model N community and look forward to continuing to attract and partner with the major innovators in the Life Science industry," said Sujay Jadhav, Life Sciences General Manager at Model N. "With many of the leading global Life Science companies running SAP solutions, our joining the SAP PartnerEdge program is indicative of the commitment we have made to leveraging and adding value to the significant investments the industry has made in enterprise ERP software."

Supporting Links

Model N at SAP EcoHub
Model N Life Sciences Revenue Management
Gartner Case Study: Global Pharma Leader Gains Significant ROI from Revenue Management

About Model N

Model N is a leader in Revenue Management solutions, offering an integrated suite of applications for analytics, pricing strategy and execution, contracts, compliance, and settlements optimized for the industry practices of Life Science and High Tech companies.

Model N is a mark of Model N, Inc. SAP, SAP PartnerEdge and all SAP logos are trademarks or registered trademarks of SAP AG in Germany and in several other countries. All other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sean Cassidy
Visit website